文献速递慢性静脉疾病静脉血栓栓塞

单侧髂静脉支架置入后支架位置与对侧深静脉血栓的关系

Postinsertion iliac vein stent position and relationship to contralateral deep vein thrombosis after unilateral iliac vein stenting.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-07-10

结果显示近40%患者支架完全覆盖对侧髂静脉开口,且开口覆盖程度每增加10个百分点,对侧深静脉血栓风险增加61%。

要点

  • 单侧髂静脉支架置入后39.3%完全覆盖对侧髂静脉开口,支架类型无显著差异。
  • 对侧髂静脉开口覆盖每增加10个百分点,对侧深静脉血栓风险增加61%(HR 1.61)。
  • 支架置入时应避免完全覆盖对侧髂静脉开口以减少对侧血栓风险。

核心结论

  • 近40%单侧髂静脉支架置入患者支架完全覆盖对侧髂静脉开口,镍钛支架未降低覆盖率。
  • 完全覆盖对侧开口与对侧髂静脉血栓风险增加相关,置入时应避免。

研究设计与样本

  • 通过支架置入后CT/MR三维重建评估支架位置及对侧开口覆盖情况。
  • 比较Elgiloy支架(36.8%)与镍钛静脉支架(63.2%)的特征,中位随访3.3±3.4年。

主要发现

  • 64例(39.3%)支架完全覆盖对侧髂静脉开口,Elgiloy支架31.7%,镍钛支架43.7%,无显著差异。
  • 汇合处支架持续压缩>25%见于9.8%的Elgiloy支架和6.8%的镍钛支架。
  • 5年对侧髂静脉血栓发生率为8.0%,完全覆盖对侧开口者更常见(P = .046)。
  • 调整肢体侧别后,开口覆盖每增加10个百分点,对侧深静脉血栓风险增加61%(HR 1.61,95%CI 1.20-2.15,P = .001)。
  • 支架类型与对侧髂静脉深静脉血栓发生率无关。

关键数值与推荐

  • 对侧髂静脉开口完全覆盖定义为支架完全跨越整个对侧髂静脉开口(100%)。
  • 对侧髂静脉血栓发生率在完全覆盖者为8.0% at 5 years,开口覆盖每增加10个百分点HR 1.61(95%CI 1.20-2.15,P = .001)。

临床怎么用

  • 置入髂静脉支架时应尽量避免完全覆盖对侧髂静脉开口以降低对侧深静脉血栓风险。
  • 术后影像评估支架位置及对侧开口覆盖情况有助于识别血栓高危患者。

局限性

  • 回顾性研究设计。
  • 需要长期随访以完全确定对侧血栓发生率及其与支架类型或位置的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Nitinol stents designed for the treatment of iliac venous obstructive lesions were expected to improve shortcomings associated with previously available stents, including accuracy of deployment at the iliac confluence and insufficient stent expansion at the site of compressive obstruction. Comparative studies to measure these characteristics have not been reported. This study was performed to measure the position of venous stents after insertion and the effect of coverage of the contralateral iliac orifice, comparing nitinol venous (NV) stents to Elgiloy stents (Boston Scientific Corporation; WALLSTENT Endoprosthesis). METHODS: Patients with a history of iliac venous stent insertion where the proximal end of the stent was placed at the iliac confluence were identified retrospectively. Patients studied with a poststent computed tomography/magnetic resonance scan that allowed examination of the position of the previously placed stent were selected for study inclusion. Imaging was reviewed using three-dimensional reconstructions to determine the accuracy of stent deployment at the iliac confluence and the position of the stent relative to the contralateral iliac orifice. The incidence of residual iliac obstruction after stent insertion, and the incidence of poststent ipsilateral or contralateral thrombosis was determined. RESULTS: One hundred sixty-three patients with iliac vein stent were identified with poststent axial imaging with a median age of 61 years. In total, 66.3% patients were female, and 73.6% were Caucasian. Stent insertion was performed on the left side in 87.1% of cases. Stenting was performed with Elgiloy stents in 36.8% of cases and NV stents in 63.2% with median follow-up of 3.3 ± 3.4 years. In 64 cases (39.3%), stents completely extended across the entire (100%) contralateral iliac orifice, with no significant difference in incidence between Elgiloy stents (31.7%) and NV stents (43.7%). Persistent stent compression >25% at the confluence was seen in 9.8% of Elgiloy stents and 6.8% of NV stents. Contralateral iliac vein thrombosis after stenting occurred in 8.0% of patients at 5 years and was statistically more frequent in those where the iliac stent was placed completely across the contralateral iliac orifice (P = .046). On Cox regression adjusted for limb laterality, each 10 percentage-point increase in orifice obstruction was associated with a 61% increase in the hazard of contralateral deep vein thrombosis (hazard ratio, 1.61; 95% confidence interval, 1.20-2.15; P = .001). Stent type was not associated with the incidence of contralateral iliac deep vein thrombosis. CONCLUSIONS: Complete coverage of the contralateral iliac orifice was found in almost 40% of patients after unilateral iliac vein stenting. The use of NV stents did not result in a decreased incidence of contralateral coverage. Contralateral iliac vein thrombosis was more frequent after complete coverage of the contralateral iliac orifice suggesting that this should be avoided at the time of stent insertion. Long-term follow up is required to fully determine the incidence of this complication and its relationship to stent type or stent positioning.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Jacob A, Theis C, Betancourt A, et al. Postinsertion iliac vein stent position and relationship to contralateral deep vein thrombosis after unilateral iliac vein stenting. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42431372. doi:10.1016/j.jvsv.2026.102577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。